🚀 VC round data is live in beta, check it out!
Aier EYE Hospital Group Valuation Multiples
Discover revenue and EBITDA valuation multiples for Aier EYE Hospital Group and similar public comparables like Apollo Hospitals, Universal Health Services, Mayapada Hospital, Encompass Health and more.
Aier EYE Hospital Group Overview
About Aier EYE Hospital Group
Aier Eye Hospital Group Co Ltd provides international ophthalmic technology and management services in China. The company offers services in myopia surgery, cataract surgery, pediatric eye plastic surgery, myopia prevention, and control to patients. The group also enables high-standard medical care.
Founded
2003
HQ
Employees
42.7K
Website
Sectors
Financials (LTM)
EV
$13B
Aier EYE Hospital Group Financials
Aier EYE Hospital Group reported last 12-month revenue of $3B and EBITDA of $1B.
In the same LTM period, Aier EYE Hospital Group generated $2B in gross profit, $1B in EBITDA, and $552M in net income.
Revenue (LTM)
Aier EYE Hospital Group P&L
In the most recent fiscal year, Aier EYE Hospital Group reported revenue of $3B and EBITDA of $945M.
Aier EYE Hospital Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $3B | XXX | $3B | XXX | XXX | XXX |
| Gross Profit | $2B | XXX | $1B | XXX | XXX | XXX |
| Gross Margin | 48% | XXX | 48% | XXX | XXX | XXX |
| EBITDA | $1B | XXX | $945M | XXX | XXX | XXX |
| EBITDA Margin | 30% | XXX | 31% | XXX | XXX | XXX |
| EBIT Margin | 22% | XXX | 23% | XXX | XXX | XXX |
| Net Profit | $552M | XXX | $521M | XXX | XXX | XXX |
| Net Margin | 16% | XXX | 17% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Aier EYE Hospital Group Stock Performance
Aier EYE Hospital Group has current market cap of $13B, and enterprise value of $13B.
Market Cap Evolution
Aier EYE Hospital Group's stock price is $1.39.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $13B | $13B | -1.3% | XXX | XXX | XXX | $0.06 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAier EYE Hospital Group Valuation Multiples
Aier EYE Hospital Group trades at 3.8x EV/Revenue multiple, and 12.9x EV/EBITDA.
EV / Revenue (LTM)
Aier EYE Hospital Group Financial Valuation Multiples
As of April 18, 2026, Aier EYE Hospital Group has market cap of $13B and EV of $13B.
Equity research analysts estimate Aier EYE Hospital Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Aier EYE Hospital Group has a P/E ratio of 23.4x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $13B | XXX | $13B | XXX | XXX | XXX |
| EV (current) | $13B | XXX | $13B | XXX | XXX | XXX |
| EV/Revenue | 3.8x | XXX | 4.2x | XXX | XXX | XXX |
| EV/EBITDA | 12.9x | XXX | 13.7x | XXX | XXX | XXX |
| EV/EBIT | 17.2x | XXX | 18.5x | XXX | XXX | XXX |
| EV/Gross Profit | 8.0x | XXX | 8.8x | XXX | XXX | XXX |
| P/E | 23.4x | XXX | 24.8x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 19.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Aier EYE Hospital Group Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Aier EYE Hospital Group Margins & Growth Rates
Aier EYE Hospital Group's revenue in the last 12 month grew by 9%.
Aier EYE Hospital Group's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.
Aier EYE Hospital Group's rule of 40 is 39% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Aier EYE Hospital Group's rule of X is 54% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Aier EYE Hospital Group Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 9% | XXX | 7% | XXX | XXX | XXX |
| EBITDA Margin | 30% | XXX | 31% | XXX | XXX | XXX |
| EBITDA Growth | 11% | XXX | 2% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 39% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 54% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 10% | XXX | 10% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 13% | XXX | 13% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 1% | XXX | 2% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 25% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Aier EYE Hospital Group Public Comps
See public comps and valuation multiples for other Hospitals & Clinics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Aier EYE Hospital Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Apollo Hospitals | XXX | XXX | XXX | XXX | XXX | XXX |
| Universal Health Services | XXX | XXX | XXX | XXX | XXX | XXX |
| Mayapada Hospital | XXX | XXX | XXX | XXX | XXX | XXX |
| Encompass Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Max Healthcare Institute | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Aier EYE Hospital Group M&A Activity
Aier EYE Hospital Group acquired XXX companies to date.
Last acquisition by Aier EYE Hospital Group was on XXXXXXXX, XXXXX. Aier EYE Hospital Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Aier EYE Hospital Group
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialAier EYE Hospital Group Investment Activity
Aier EYE Hospital Group invested in XXX companies to date.
Aier EYE Hospital Group made its latest investment on XXXXXXXX, XXXXX. Aier EYE Hospital Group invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Aier EYE Hospital Group
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Aier EYE Hospital Group
| When was Aier EYE Hospital Group founded? | Aier EYE Hospital Group was founded in 2003. |
| Where is Aier EYE Hospital Group headquartered? | Aier EYE Hospital Group is headquartered in China. |
| How many employees does Aier EYE Hospital Group have? | As of today, Aier EYE Hospital Group has over 42K employees. |
| Who is the CEO of Aier EYE Hospital Group? | Aier EYE Hospital Group's CEO is Zhong Han. |
| Is Aier EYE Hospital Group publicly listed? | Yes, Aier EYE Hospital Group is a public company listed on Shenzhen Stock Exchange. |
| What is the stock symbol of Aier EYE Hospital Group? | Aier EYE Hospital Group trades under 300015 ticker. |
| When did Aier EYE Hospital Group go public? | Aier EYE Hospital Group went public in 2009. |
| Who are competitors of Aier EYE Hospital Group? | Aier EYE Hospital Group main competitors are Apollo Hospitals, Universal Health Services, Mayapada Hospital, Encompass Health. |
| What is the current market cap of Aier EYE Hospital Group? | Aier EYE Hospital Group's current market cap is $13B. |
| What is the current revenue of Aier EYE Hospital Group? | Aier EYE Hospital Group's last 12 months revenue is $3B. |
| What is the current revenue growth of Aier EYE Hospital Group? | Aier EYE Hospital Group revenue growth (NTM/LTM) is 9%. |
| What is the current EV/Revenue multiple of Aier EYE Hospital Group? | Current revenue multiple of Aier EYE Hospital Group is 3.8x. |
| Is Aier EYE Hospital Group profitable? | Yes, Aier EYE Hospital Group is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Aier EYE Hospital Group? | Aier EYE Hospital Group's last 12 months EBITDA is $1B. |
| What is Aier EYE Hospital Group's EBITDA margin? | Aier EYE Hospital Group's last 12 months EBITDA margin is 30%. |
| What is the current EV/EBITDA multiple of Aier EYE Hospital Group? | Current EBITDA multiple of Aier EYE Hospital Group is 12.9x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.